A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

RecruitingOBSERVATIONAL
Enrollment

305

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2026

Conditions
Non Small Cell Lung Cancer
Interventions
DIAGNOSTIC_TEST

MRD

MRD(LC-10)include 10 lung cancer-related driver gene mutation site

Trial Locations (11)

Unknown

RECRUITING

First Affiliated Hospital of Xiamen University, Xiamen

RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

RECRUITING

Affiliated Cancer Hospital of Harbin Medical University, Harbin

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

Shandong Provincial Hospital, Jinan

RECRUITING

Shanghai Chest hospital, Shanghai

RECRUITING

Zhongshan Hospital Affiliated to Fudan University, Shanghai

RECRUITING

Shanxi Cancer Hospital, Taiyuan

RECRUITING

The First Affiliated Hospital of Xi 'an Jiaotong University, Xi’an

RECRUITING

The First Affiliated Hospital of Zhejiang University, Hangzhou

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Shanghai Chest Hospital

OTHER